{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"5"}]}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"3"},{"groupId":"OG001","value":"6"}],"units":"Participants"}],"description":"Maximum Tolerated Dose","groups":[{"description":"2mg Pomolidomide per day per Cycle (Cycle = 28 days)","id":"OG000","title":"Cohort 2"},{"description":"1mg Pomolidomide per day per Cycle (Cycle = 28 days)","id":"OG001","title":"Cohort 3"}],"paramType":"COUNT_OF_PARTICIPANTS","reportingStatus":"POSTED","timeFrame":"Participants Experiencing Study Medication Maximum Tolerated Dose through Study Completion (Avg. 1 Year)","title":"Number of Patients Experiencing MTD","type":"PRIMARY","unitOfMeasure":"Participants"}